Highlights and Quick Summary
- Cash and Short Term Investments for the quarter ending September 30, 2022 was $1.09 Billion (a -6.14% decrease compared to previous quarter)
- Year-over-year quarterly Cash and Short Term Investments increased by 13.35%
- Annual Cash and Short Term Investments for 2021 was $966 Million (a 222.24% increase from previous year)
- Annual Cash and Short Term Investments for 2020 was $300 Million (a 226.27% increase from previous year)
- Annual Cash and Short Term Investments for 2019 was $91.8 Million (a -37.28% decrease from previous year)
Visit stockrow.com/BEAM
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Cash and Short Term Investments of Beam Therapeutics Inc.
Most recent Cash and Short Term Investmentsof BEAM including historical data for past 10 years.Interactive Chart of Cash and Short Term Investments of Beam Therapeutics Inc.
Beam Therapeutics Inc. Cash and Short Term Investments for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | $1,094.55 | $1,166.12 | $1,222.6 | – |
| 2021 | $965.65 | $933.41 | $615.28 | $503.48 | $965.65 |
| 2020 | $299.67 | $202.22 | $227.95 | $253.44 | $299.67 |
| 2019 | – | – | – | $91.85 | $91.85 |
| 2018 | – | – | – | $146.44 | $146.44 |
| 2017 | – | – | – | – | $2.0 |
Business Profile of Beam Therapeutics Inc.
Sector: Healthcare
Industry: Biotechnology